Travel Vaccines Market Size & Share | Industry Growth 2028
Posted by mahesh on October 10th, 2022
According to our latest research study, titled "Global Travel Vaccines Market Forecast to 2028 – COVID-19 Impact and Analysis – by Product and Application," the market is expected to reach US$ 5,914.22 million by 2028 from US$ 3,078.94 million in 2021. It is estimated to grow at a CAGR of 9.8% from 2021 to 2028. The report highlights trends prevailing in the market and factors governing its growth. The rapid growth of the travel and tourism sector, prevention of transnational infections, and the rising incidence of infectious diseases contribute to the market’s progress. However, the high cost of travel vaccines hinders the market's growth.
Travel vaccines, also called travel immunizations, are vaccinations for travelers can get before visiting certain regions of the world, which help protect them from serious infections and diseases common in the areas where the traveler is going to. Travel vaccines are safe, effective ways to protect travelers from bringing home infections that can lead to endemics or outbreaks. They are intended to protect travelers and to prevent disease outbreaks within and between countries. Some countries even require proof of vaccination for travelers traveling to or from a country. The rapid growth of the travel and tourism sector and the rising incidence of infectious diseases contribute to the market progress. However, the high cost of travel vaccines hinders the travel vaccines market growth.
To get sample Copy of the report, along with the TOC, Statistics @ https://www.theinsightpartners.com/sample/TIPRE00007439/
Here we have listed the top Travel Vaccines Drugs Market companies
GlaxoSmithKline plc,Merck & Co., Inc.,Sanofi,Novartis AG,Pfizer Inc.,Dynavax Technologies,Emergent BioSolutions Inc.,Abbott,Bharat Biotech,Valneva SE.
Highlights the following key factors:
1) Business description-A detailed description of the company's operations and business divisions.
2) Corporate strategy - Analyst's summarization of the company's business strategy.
3) SWOT Analysis-A detailed analysis of the company's strengths, weakness, opportunities, and threats.
4) Company history - Progression of key events associated with the company.
5) Major products and services-A list of major products, services, and brands of the company.
6) Key competitors - A list of key competitors to the company.
7) Important locations and subsidiaries - A list and contact details of key locations and subsidiaries of the company.
8) Detailed financial ratios for the past five years - The latest financial ratios derived from the annual financial statements published by the company with 7 years history.
The Covid-19 (coronavirus) pandemic is impacting society and the overall economy across the world. The impact of this pandemic is growing day by day as well as affecting the supply chain. The COVID-19 crisis is creating uncertainty in the stock market, massive slowing of supply chain, falling business confidence, and increasing panic among the customer segments. The overall effect of the pandemic is impacting the production process of several industries including Biotechnology, medical devices, pharma Industry, and many more. Trade barriers are further restraining the demand- supply outlook. As government of different regions have already announced total lockdown and temporarily shutdown of industries, the overall production process being adversely affected; thus, hinder the overall Travel Vaccines Drugs market globally. This report on 'Travel Vaccines Drugs market' provides the analysis on impact on Covid-19 on various business segments and country markets. The report also showcases market trends and forecast to 2028, factoring the impact of Covid -19 Situation.
In terms of type, the Travel Vaccines Drugs in healthcare market is segmented on Based on therapeutic class the market is segmented as, targeted therapy and immunotherapy. Based on pharmacologic class the market is segmented as, angiogenesis inhibitors, mTOR inhibitors, monoclonal antibodies, and cytokine immunotherapy (IL-2).
The report provides a detailed overview of the industry including both qualitative and quantitative information. It provides overview and forecast of the global Travel Vaccines Drugs Market based on product and application. It also provides market size and forecast till 2028 for overall Travel Vaccines Drugs Market with respect to five major regions, namely; North America, Europe, Asia-Pacific (APAC), Middle East and Africa (MEA) and South America (SAM), which is later sub-segmented by respective countries and segments. The report evaluates market dynamics effecting the market during the forecast period i.e., drivers, restraints, opportunities, and future trend and provides exhaustive PEST analysis for all five regions.
Access Full Report @ https://www.theinsightpartners.com/reports/travel-vaccines-market
The Insight Partners is a one stop industry research provider of actionable intelligence. We help our clients in getting solutions to their research requirements through our syndicated and consulting research services. We are a specialist in Life Science, Technology, Healthcare, Manufacturing, Automotive and Defense, Food Beverages, Chemical etc.
If you have any queries about this report or if you would like further information, please contact us:
Contact Person: Sameer Joshi
Like it? Share it!
About the Authormahesh
Joined: September 20th, 2022
Articles Posted: 71
More by this author